ASCO: NSCLC Tumor Profiling and Biomarker-Guided Therapy are Feasible

A massive French database study shows that genetic tumor profiling in patients with non–small-cell lung cancer (NSCLC) is feasible, and is already helping physicians guide treatment in many patients, according to results presented at the American Society of Clinical Oncology annual meeting.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news